Yahoo · Aug 26, 2026
Are Wall Street Analysts Bullish on Labcorp Holdings Stock?
Do Wall Street analysts favor Labcorp’s stock, given its solid performance?
NASDAQ · LH
Labcorp Holdings Inc.
Healthcare · Medical - Equipment & Services
$335.11
Down-$2.00 (-0.60%)
Updated Aug 31, 2026, 5:50 PM
SID Score
7.4/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 21.94B
- P/E ratio
- 25.71
- Dividend yield
- 0.86%
- 52-week range
- $245.00 – $341.80
- Volume
- 456.55K
- Avg. volume
- 774.33K
Price performance
LH price history
1M range · 20 trading sessions · Daily adjusted prices
LH closed at $335.11 after 20 trading sessions, up 9.01% for the selected period.
- Last close
- $335.11
- Period change
- +9.01%
- Period low
- $307.42
- Period high
- $339.34
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $336.39 | $337.69 | $334.42 | $335.11 | 456.55K |
| Aug 27, 2026 | $333.37 | $341.795 | $331.42 | $336.54 | 673.63K |
| Aug 26, 2026 | $335.83 | $339.40 | $334.41 | $335.72 | 701.21K |
| Aug 25, 2026 | $338.58 | $339.76 | $333.53 | $337.68 | 697.43K |
| Aug 24, 2026 | $335.99 | $339.76 | $334.40 | $339.34 | 466.31K |
| Aug 21, 2026 | $332.68 | $336.90 | $330.90 | $336.34 | 792.68K |
| Aug 20, 2026 | $326.76 | $338.19 | $326.74 | $332.81 | 731.85K |
| Aug 19, 2026 | $324.49 | $331.20 | $323.41 | $330.44 | 518.29K |
| Aug 18, 2026 | $326.07 | $329.47 | $322.18 | $322.18 | 588.86K |
| Aug 17, 2026 | $318.02 | $326.895 | $316.56 | $323.34 | 786.56K |
| Aug 14, 2026 | $317.35 | $322.99 | $317.06 | $318.13 | 436.29K |
| Aug 13, 2026 | $325.00 | $325.58 | $321.275 | $322.59 | 352.5K |
| Aug 12, 2026 | $316.13 | $323.63 | $315.3302 | $323.48 | 365.96K |
| Aug 11, 2026 | $320.37 | $323.97 | $319.01 | $322.42 | 512.67K |
| Aug 10, 2026 | $318.27 | $321.46 | $316.70 | $321.31 | 538.46K |
| Aug 7, 2026 | $316.40 | $319.935 | $313.32 | $319.17 | 429.35K |
| Aug 6, 2026 | $316.83 | $317.10 | $312.30 | $316.53 | 440.06K |
| Aug 5, 2026 | $313.41 | $315.435 | $310.905 | $313.96 | 502.48K |
| Aug 4, 2026 | $306.79 | $312.96 | $300.58 | $312.34 | 748.5K |
| Aug 3, 2026 | $310.03 | $312.99 | $307.04 | $307.42 | 726.95K |
Latest LH news
The latest Smart Investors Daily articles mentioning LH.
Stock researchCompany · Overview
LH research
Overview
Company profile and research snapshot.
Company profile
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $314.43
- Implied upside
- —
- Analysts
- 29
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 4, 2026 | Piper Sandler | Neutral | — |
| Aug 3, 2026 | JP Morgan | Overweight | — |
| Jul 31, 2026 | Truist Securities | Buy | — |
| Jul 31, 2026 | Barclays | Equal-Weight | — |
| Jul 31, 2026 | Morgan Stanley | Overweight | — |
News briefing
No generated briefing is available yet.
Yahoo · Aug 25, 2026
3 Reasons LH is Risky and 1 Stock to Buy Instead
Over the past six months, Labcorp has been a great trade, beating the S&P 500 by 9.5%. Its stock price has climbed to $339.34, representing a healthy 20% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Yahoo · Aug 25, 2026
Danaher Rides on Strength in Biotechnology Segment: Will It Sustain?
DHR's Biotechnology segment grows as China demand, bioprocessing and improving discovery markets offset regional headwinds.
Yahoo · Aug 25, 2026
Should You Continue to Hold Labcorp Stock in Your Portfolio?
LH's specialty-testing expansion, strategic partnerships and buybacks support growth, while reimbursement and cost pressures pose risks.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
